EUVIMEDEUVIMED entdecken
Crossref

Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity

Manfred Anim, Georgios Sogkas, Nadezhda Camacho-Ordonez, Gunnar Schmidt, Abdulwahab Elsayed, Michele Proietti, Torsten Witte, Bodo Grimbacher, Faranaz Atschekzei

Clinical Immunology · 2024

DOI: 10.1016/j.clim.2024.110326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Manfred Anim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; Hannover Biomedical Research School (HBRS), Hannover Medical S…. Hauptthemen laut MEDLINE: Common Variable Immunodeficiency, Autoimmunity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Infektionsforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a transcriptional regulator, functioning a transcriptional corepressor by interacting with the interferon regulatory factor-2. The ubiquitous expression of IRF2BP2 by diverse cell types and tissues suggests its potential involvement in different cell signalling pathways. Variants inIRF2BP2have been recently identified to cause familial common variable immunodeficiency (CVID) characterized by immune dysregulation. This study investigated three rare novel variants inIRF2BP2, identified in patients with primary antibody deficiency and autoimmunity by whole exome-sequencing (WES). Following transient overexpression of EGFP-fused mutants in HEK293 cells and transfection in Jurkat cell lines, we used fluorescence microscopy, real-time PCR and Western blotting to analyze their effects on IRF2BP2 expression, subcellular localization, nuclear translocation of IRF2, and the transcriptional activation of NFκB1(p50). We found altered IRF2BP2 mRNA and protein expression levels in the mutants compared to the wild type after IRF2BP2 overexpression. In confocal fluorescence microscopy, variants in the C-terminal RING finger domain showed an irregular aggregate formation and distribution instead of the expected nuclear localization compared to the variants in the N-terminal zinc finger domain and their wildtype counterpart. Immunoblotting revealed an impaired IRF2 and NFκB1 (p50) nuclear localization in the mutants compared to the IRF2BP2 wildtype counterpart. LPS stimulation reduced IRF2BP2 mRNA expression in the variants compared to the wild type. Our findings significantly contribute to understanding the clinical significance of IRF2BP2 mutations in the pathogenesis of immunodeficiency and immune dysregulation. We observed impairment of the nuclear translocation of IRF2 and NFκB1 (p50) due to the upregulation of IRF2BP2, potentially affecting specific gene expressions involved in immune regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Common Variable ImmunodeficiencyAutoimmunityHumansHEK293 CellsJurkat CellsInterferon Regulatory Factor-2MaleFemaleMutationNF-kappa B p50 SubunitExome SequencingCo-Repressor ProteinsDNA-Binding ProteinsTranscription Factors

Stichwörter der Autor:innen

CVIDIRF2BP2 (IFN regulatory factor 2 binding protein 2)Immune dysregulationNFκB1 (p50)Primary immunodeficiency

Substanzen

IRF2BP2 protein, humanInterferon Regulatory Factor-2IRF2 protein, humanNF-kappa B p50 SubunitCo-Repressor ProteinsDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; Hannover Biomedical Research School (HBRS), Hannover Medical School, Hanover, Germany.
  • Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; RESIST - Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg, Hanover, Germany.
  • Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freib…
  • Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; RESIST - Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg, Hanover, Germany.; Institute for Immunodef…

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum für Infektionsforschung

Zitieren

APA

Anim, M., Sogkas, G., Camacho-Ordonez, N., Schmidt, G., Elsayed, A., Proietti, M., Witte, T., Grimbacher, B., & Atschekzei, F. (2024). Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110326

Vancouver

Anim M, Sogkas G, Camacho-Ordonez N, Schmidt G, Elsayed A, Proietti M, et al. Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110326

BibTeX
@article{Anim2024,
  author = {Anim, Manfred and Sogkas, Georgios and Camacho-Ordonez, Nadezhda and Schmidt, Gunnar and Elsayed, Abdulwahab and Proietti, Michele and Witte, Torsten and Grimbacher, Bodo and Atschekzei, Faranaz},
  title = {Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity},
  journal = {Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.clim.2024.110326}
}
Kostenlos starten →